On Dec. 23, 2022, federal agencies released an FAQ stating that they will not initiate enforcement action against any plan or issuer that makes a good faith effort to submit their prescription drug data by Jan. 31, 2023. Read more…
The IRS released a final rule that extends the annual furnishing deadlines for Sections 6055 and 6056 reporting under the Affordable Care Act (ACA). This rule finalizes guidance that was proposed by the IRS in December 2021. Due to the deadline extension, employers subject to ACA reporting have until March 2, 2023 to furnish statements for the 2022 calendar year. Read more…